Vorscot Tablets SpecificationRequires Prescription (YES/NO)YesGenericsVortioxetineUsed ForDepressionHow it worksThe mechanism of action of vortioxetine is thought to be related to its direct modulation of serotonergic receptor activity and inhibition of the serotonin (5-HT) transporter. Nonclinical data indicate that vortioxetine is a 5-HT3, 5-HT7, and 5-HT1D?receptor antagonist, 5-HT1B?receptor partial agonist, 5-HT1A?receptor agonist and inhibitor of the 5-HT transporter, leading to modulation of neurotransmission in several systems, including predominantly the serotonin but probably also the norepinephrine, dopamine, histamine, acetylcholine, GABA and glutamate systems. This multimodal activity is considered responsible for the antidepressant and anxiolytic-like effects and the improvement of cognitive function, learning and memory observed with vortioxetine.Vorscot Tablets Usage And SafetyDosageVortioxetineSide EffectsVery common: may affect more than 1 in 10 people - Nausea ; Common: may affect up to 1 in 10 people - Diarrhoea, constipation, vomiting ,dizziness, itching of the whole body,abnormal dreams ; Uncommon: may affect up to 1 in 100 people - Flushing , night sweats .Drug InteractionsPhenelzine, iproniazid, isocarboxazid, nialamide, tranylcypromine , moclobemide , selegiline, rasagiline , linezolid , lithium , rifampicin , carbamazepine, phenytoin , warfarin, dipyridamole, phenprocoumon, low-dose acetylsalicylic acid , sumatriptan , tramadol , mefloquine , bupropion , fluoxetine, paroxetine , St John?s wort , quinidine , chlorpromazine, chlorprothixene, haloperidol .IndicationIt is used to treat major depressive episodes in adults .When not to UseDo not take -If you are allergic to vortioxetine or any of the other ingredients of this medicine . If you are taking other medicines for depression known as non-selective monoamine oxidase inhibitors or selective MAO-A inhibitors. Ask your doctor if you are uncertain.Vorscot Tablets PrecautionsPrecautionVortioxetine should be used with caution in patients with a history of mania/hypomania and should be discontinued in any patient entering a manic phase.Vorscot Tablets WarningsWarning 1Depression is associated with an increased risk of suicidal thoughts, self harm and suicide (suicide-related events). This risk persists until significant remission occurs. As improvement may not occur during the first few weeks or more of treatment, patients should be closely monitored until such improvement occurs. It is general clinical experience that the risk of suicide may increase in the early stages of recovery.Warning 2Seizures are a potential risk with antidepressants. Therefore, vortioxetine should be introduced cautiously in patients who have a history of seizures or in patients with unstable epilepsy . Treatment should be discontinued in any patient who develops seizures or for whom there is an increase in seizure frequency.Warning 3Patients treated with antidepressants, including vortioxetine, may also experience feelings of aggression, anger, agitation and irritability. Patient's condition and disease status should be closely monitored. Patients (and caregivers of patients) should be alerted to seek medical advice, if aggressive/agitated behaviour emerges or aggravates.Vorscot Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.
₦19,852.00
COETRIE CAP 10`S ₦8,559.50
GLIMESTAR M 3MG FORTE TAB 10`S ₦2,470.00
CALCIQUICK SUPER TAB 15`S ₦3,753.75
ENCELIN M 50/500MG TAB 10`S ₦1,718.00
Living Proof Full Conditioner 236ml ₦68,151.12
Vorscot Tablets SpecificationRequires Prescription (YES/NO)YesGenericsVortioxetineUsed ForDepressionHow it worksThe mechanism of action of vortioxetine is thought to be related to its direct modulation of serotonergic receptor activity and inhibition of the serotonin (5-HT) transporter. Nonclinical data indicate that vortioxetine is a 5-HT3, 5-HT7, and 5-HT1D?receptor antagonist, 5-HT1B?receptor partial agonist, 5-HT1A?receptor agonist and inhibitor of the 5-HT transporter, leading to modulation of neurotransmission in several systems, including predominantly the serotonin but probably also the norepinephrine, dopamine, histamine, acetylcholine, GABA and glutamate systems. This multimodal activity is considered responsible for the antidepressant and anxiolytic-like effects and the improvement of cognitive function, learning and memory observed with vortioxetine.Vorscot Tablets Usage And SafetyDosageVortioxetineSide EffectsVery common: may affect more than 1 in 10 people - Nausea ; Common: may affect up to 1 in 10 people - Diarrhoea, constipation, vomiting ,dizziness, itching of the whole body,abnormal dreams ; Uncommon: may affect up to 1 in 100 people - Flushing , night sweats .Drug InteractionsPhenelzine, iproniazid, isocarboxazid, nialamide, tranylcypromine , moclobemide , selegiline, rasagiline , linezolid , lithium , rifampicin , carbamazepine, phenytoin , warfarin, dipyridamole, phenprocoumon, low-dose acetylsalicylic acid , sumatriptan , tramadol , mefloquine , bupropion , fluoxetine, paroxetine , St John?s wort , quinidine , chlorpromazine, chlorprothixene, haloperidol .IndicationIt is used to treat major depressive episodes in adults .When not to UseDo not take -If you are allergic to vortioxetine or any of the other ingredients of this medicine . If you are taking other medicines for depression known as non-selective monoamine oxidase inhibitors or selective MAO-A inhibitors. Ask your doctor if you are uncertain.Vorscot Tablets PrecautionsPrecautionVortioxetine should be used with caution in patients with a history of mania/hypomania and should be discontinued in any patient entering a manic phase.Vorscot Tablets WarningsWarning 1Depression is associated with an increased risk of suicidal thoughts, self harm and suicide (suicide-related events). This risk persists until significant remission occurs. As improvement may not occur during the first few weeks or more of treatment, patients should be closely monitored until such improvement occurs. It is general clinical experience that the risk of suicide may increase in the early stages of recovery.Warning 2Seizures are a potential risk with antidepressants. Therefore, vortioxetine should be introduced cautiously in patients who have a history of seizures or in patients with unstable epilepsy . Treatment should be discontinued in any patient who develops seizures or for whom there is an increase in seizure frequency.Warning 3Patients treated with antidepressants, including vortioxetine, may also experience feelings of aggression, anger, agitation and irritability. Patient's condition and disease status should be closely monitored. Patients (and caregivers of patients) should be alerted to seek medical advice, if aggressive/agitated behaviour emerges or aggravates.Vorscot Tablets Additional InformationPregnancy categoryAlways consult your physician before using any medicine.Storage (YES/NO)Store this medicine at room temperature, away from direct light and heat.